Respiratory Syncytial Virus - KidsHealth

1. Hall CB. Respiratory syncytial virus and parainfluenza virus.  ;344:-
Photo provided by Flickr

Respiratory syncytial virus (RSV) in babies | BabyCenter

30. Nielsen HE, Siersma V, Andersen S, et al. Respiratory syncytial virus infection -- risk factors for hospital admission: a case-control study. ;92:-

4. Hart RJC. An outbreak of respiratory syncytial virus infection in an old people's home.  ;8:-
Photo provided by Flickr

Respiratory Syncytial Virus (RSV) Infection-Topic Overview

9. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. ;174:-

6. Respiratory syncytial virus infection in the elderly 1976-1982.  ;287:-
Photo provided by Flickr

32. Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. ;115:-

7. Vikerfors T, Grandien M, Olcen P. Respiratory syncytial virus infections in adults.  ;136:-
Photo provided by Flickr

096131: Respiratory Syncytial Virus (RSV) Antibodies | LabCorp

Respiratory syncytial virus (RSV) was first recognized in 1957 as a cause of bronchiolitis in infants and is the most commonly identified cause of lower respiratory tract infection in young children. Mild illness in young adults with reinfection was described and confirmed in subsequent family studies. However, RSV was not recognized as a potentially serious problem in older adults until the 1970s, when outbreaks of the virus occurred in long-term care facilities. Since then, additional studies in hospitalized adults have suggested that RSV may be an important cause of illness in community-dwelling elderly people. Most previous studies used insensitive viral culture or retrospective serologic studies for diagnosis, a practice that led to widely variable assessments of the incidence and effects of the disease. Recent estimates of the disease burden of RSV in adults have been based on mathematical models linking viral activity in children with hospitalization and death in adults, and Thompson et al. have estimated that RSV accounts for approximately 10,000 deaths annually in the United States in persons over the age of 65 years. Although these estimates are useful, their accuracy is confounded by cocirculation of other respiratory viruses with indistinguishable clinical syndromes and is limited by the assumption that viral activity in infants reflects events in elderly populations. These results have stimulated interest in vaccines and other treatments for RSV in adults. However, additional data regarding virus-specific epidemiology and disease effects, particularly in community-dwelling elderly persons and high-risk adults, are needed before embarking on costly vaccine trials.

Respiratory Syncytial Virus (RSV) - Healthery

There are no medications used to treat the virus itself. Care of a baby with RSV involves treating the effects of the virus on the respiratory system. Because a virus causes the illness, antibiotics are not useful. Treatment may include:

Respiratory Syncytial Virus (RSV)

RSV was identified in 919 of 5067 specimens (18%) and was associated with 20% of annual hospitalizations, 18% of emergency department visits, and 15% of office visits for acute respiratory infections from November through April. In 58 of the samples (6%), coinfecting viruses were identified, including 26 samples with influenza virus, 8 with parainfluenza virus, 11 with rhinovirus, 6 with adenovirus, 5 with cytomegalovirus, and 4 with other viruses. The circulation of strain groups was similar among sites, with RSV A predominating during 3 of 4 years. Of 753 RSV isolates that were typed, 602 (80%) were group A, 137 (18%) were group B, and 14 (2%) were determined to be both A and B by RT-PCR. RSV A strains comprised 81% of inpatient isolates and 78% of outpatient isolates (P=0.32).